Advances in breast cancer treatment have improved disease-free survival and overall
survival in women with early-stage breast cancer. However, these improvements may be …

Asymptomatic cardiotoxicity following breast cancer treatment is a significant issue for many
patients, as these patients typically face an increased risk of cardiovascular disease (CVD) …

Thanks to increasingly effective treatment, breast cancer mortality rates have significantly
declined over the past few decades. Following the increase in life expectancy of women …

Background: Current anticancer treatments for breast cancer (BC) may cause cardiotoxicity.
This study aimed to investigate the effectiveness of aerobic exercise in mitigating …

Physical activity is known to prevent the occurrence of cancer and decrease the risk of
breast cancer. At diagnosis of breast cancer, fewer than half of the patients reach the …

Advances in detection and supportive care strategies have led to improvements in cancer-
specific and overall survival after a diagnosis of early-stage breast cancer. These …

Cardio-oncology is an emerging field tasked with identifying and treating cancer therapy
related cardiac dysfunction (eg, cytotoxic agents, immunotherapies, radiation, and hormone …

Background Anthracyclines and monoclonal antibodies against human epidermal growth
factor receptor-2 (HER2) are frequently used to treat breast cancer but they are associated …

Objective Animal data suggest that exercise during chemotherapy is cardioprotective, but
clinical evidence to support this is limited. This study evaluated the effect of exercise during …

Although recent advances in curative-intent therapies are beginning to produce significant
survival gains in early breast cancer, these improvements may ultimately be attenuated by …